Date：March 25, 2024 (Monday) 10:00-11:30

Location：Multi-function Hall, Health Science Center, Zhejiang University School of Medicine

Speaker：Charles C. Zhang

Bio：

Dr. Charles C. Zhang currently serves as the Toxicology Leader at the Bill & Melinda Gates Foundation (BMGF)’s Medical Research Institute (Gates MRI), where he spearheads nonclinical safety assessment within multidisciplinary development teams. As the toxicology subject matter expert for BMGF, Charles focuses on programs dedicated to alleviating the burden of tuberculosis (TB), malaria, diarrheal diseases, and maternal, newborn, and child illnesses in low-and-middle-income countries (LMICs).

Charles earned his Ph.D. in Pharmacology from the University of Arkansas for Medical Sciences (Little Rock, AR, USA) in 2000. He holds certification (DABT) from the American Board of Toxicology (2005, 2010, 2015, 2020) in general toxicology and is currently pursuing an EMBA at the Kellogg School of Management at Northwestern University (Chicago, IL, USA), with an expected completion date in 2025.

As a seasoned entrepreneur and translational medicine expert, Charles boasts a 23-year track record leading new drug development endeavors in the biopharmaceutical industry in the USA. His achievements include authoring 2 NDA (1 as the nonclinical biology lea), 1 PMA (medical device), 8 INDs and 3 CTAs for worldwide submissions.